Updates ·
Health notices · Monday 17 August
3 notices from the agencies today, in plain words, each with the original linked.
Oma's Pride recalls Woof Complete Canine Chicken Recipe due to possible Salmonella
CDC · Food safety
If you have a dog and bought Woof Complete Canine Chicken Recipe (6 lb bag), a Centers for Disease Control and Prevention notice says one lot may be contaminated with Salmonella.
Salmonella is a germ that can make people sick after contact with contaminated food, including through handling pet food or bowls.
Check whether your bag matches the recalled lot; avoid contact with the contents and follow the recall actions listed by the company or seller.
What to do
- Use the company’s or seller’s recall instructions for the recalled lot (Lot BB012729).
FDA approval of sitagliptin phosphate for type 2 diabetes
FDA · Approval
If you have type 2 diabetes, the US Food and Drug Administration has approved sitagliptin phosphate (an oral tablet) as an add-on to diet and exercise to improve glycemic control.
Sitagliptin is a DPP-4 inhibitor, a type of medicine used to help lower blood sugar. It should not be used for type 1 diabetes.
The label also notes it has not been studied in people with a history of pancreatitis, and it is unknown whether that history increases risk while using sitagliptin.
FDA approves first oral PCSK9 inhibitor for high LDL cholesterol
FDA · Announcement
If you are an adult with high cholesterol, the FDA has approved Lipfendra (enlicitide) as an add-on to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), often called “bad” cholesterol.
PCSK9 is a protein involved in LDL-C levels. This medicine is a PCSK9 inhibitor, designed to lower LDL-C.
This means that, tomorrow, your treatment options for lowering LDL-C may include a first oral option that can be used along with diet and exercise.
Where this comes from
- Oma's Pride recalls Woof Complete Canine Chicken Recipe due to possible SalmonellaCDC — food safety
- FDA approval of sitagliptin phosphate for type 2 diabetesUS Food and Drug Administration — Drugs@FDA
- FDA approves first oral PCSK9 inhibitor for high LDL cholesterolfda-press
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.